慢性偏头痛治疗周期接近尾声时肉毒杆菌毒素的消退效应:4年临床经验

Headache: The Journal of Head and Face Pain Pub Date : 2019-11-22 DOI:10.1111/head.13713

F. Khan, A. Mohammed, M. Poongkunran, Anil K Chimakurthy, Michael Pepper

{"title":"慢性偏头痛治疗周期接近尾声时肉毒杆菌毒素的消退效应:4年临床经验","authors":"F. Khan, A. Mohammed, M. Poongkunran, Anil K Chimakurthy, Michael Pepper","doi":"10.1111/head.13713","DOIUrl":null,"url":null,"abstract":"The injection interval for onabotulinumtoxinA (BoNTA) in the management of chronic migraine (CM) is 12 weeks (78‐84 days). The aim of this study was to review patient‐reported wearing off effect (WOE) of the therapeutic benefit of BoNTA near the end of the treatment cycle. We intended to describe the demographics of patients at baseline and compare groups of patients with multiple episodes of WOE.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"15","resultStr":"{\"title\":\"Wearing Off Effect of OnabotulinumtoxinA Near the End of Treatment Cycle for Chronic Migraine: A 4‐Year Clinical Experience\",\"authors\":\"F. Khan, A. Mohammed, M. Poongkunran, Anil K Chimakurthy, Michael Pepper\",\"doi\":\"10.1111/head.13713\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The injection interval for onabotulinumtoxinA (BoNTA) in the management of chronic migraine (CM) is 12 weeks (78‐84 days). The aim of this study was to review patient‐reported wearing off effect (WOE) of the therapeutic benefit of BoNTA near the end of the treatment cycle. We intended to describe the demographics of patients at baseline and compare groups of patients with multiple episodes of WOE.\",\"PeriodicalId\":12845,\"journal\":{\"name\":\"Headache: The Journal of Head and Face Pain\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Headache: The Journal of Head and Face Pain\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/head.13713\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Headache: The Journal of Head and Face Pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/head.13713","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 15

摘要

治疗慢性偏头痛(CM)的肉毒杆菌毒素(BoNTA)注射间隔为12周(78 - 84天)。本研究的目的是回顾患者报告的BoNTA治疗周期接近结束时治疗益处的消退效应(WOE)。我们打算描述基线时患者的人口统计数据，并比较多次发作的患者组。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Wearing Off Effect of OnabotulinumtoxinA Near the End of Treatment Cycle for Chronic Migraine: A 4‐Year Clinical Experience

The injection interval for onabotulinumtoxinA (BoNTA) in the management of chronic migraine (CM) is 12 weeks (78‐84 days). The aim of this study was to review patient‐reported wearing off effect (WOE) of the therapeutic benefit of BoNTA near the end of the treatment cycle. We intended to describe the demographics of patients at baseline and compare groups of patients with multiple episodes of WOE.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Headache: The Journal of Head and Face Pain

自引率

0.00%

发文量